Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		145,013,786
Beginning balance at Dec. 31, 2022	$ 339,310	$ 1	$ 951,946	$ (233)	$ (612,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	28,733		28,733
Exercise of stock options (in shares)		355,516
Exercise of stock options	1,449		1,449
Vesting of restricted stock units (in shares)		1,257,722
Other comprehensive income (loss)	137			137
Net loss	(44,544)				(44,544)
Ending balance (in shares) at Mar. 31, 2023		146,627,024
Ending balance at Mar. 31, 2023	325,085	$ 1	982,128	(96)	(656,948)
Beginning balance (in shares) at Dec. 31, 2023		157,166,360
Beginning balance at Dec. 31, 2023	356,892	$ 2	1,076,508	80	(719,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	25,066		25,066
Exercise of stock options (in shares)		780,998
Exercise of stock options	252		252
Vesting of restricted stock units (in shares)		1,748,589
Shares withheld related to net share settlement of equity awards (in shares)		(1,142,081)
Shares withheld related to net share settlement of equity awards	$ (11,712)		(11,712)
Repurchases of common stock (in shares)	(4,962,145)	(4,962,145)
Repurchases of common stock	$ (55,511)	$ 0	(55,511)
Other comprehensive income (loss)	(154)			(154)
Net loss	(18,339)				(18,339)
Ending balance (in shares) at Mar. 31, 2024		153,591,721
Ending balance at Mar. 31, 2024	$ 296,494	$ 2	$ 1,034,603	$ (74)	$ (738,037)